Search

Search Constraints

You searched for: Author/Creator Hwu, Patrick

Search Results

1. Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report. Issue 1 (December 2016)

2. Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon‐V600 mutations in cutaneous melanoma patients. Issue 8 (2nd December 2016)

3. Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver. (November 2018)

5. A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. Issue 1 (December 2016)

6. Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma. Issue 9 (November 2018)

7. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (November 2018)

8. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD‐1 in patients with metastatic melanoma. Issue 23 (9th August 2019)

9. The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy. (18th December 2017)

10. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)